Glooko Research vs VX
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Glooko Research
This platform connects individuals with diabetes and their healthcare providers, facilitating telehealth and clinical research. It aggregates data from various health devices to provide valuable insights.
- Connects diabetes patients with healthcare professionals
- Enables telehealth and clinical research
- Aggregates data from glucose meters, CGMs, pumps, and trackers
- Secure data collection and analytics
- Remote patient monitoring
- Trial management tools
Read full descriptionHide full description
The world's most significant FDA Part 11 and HIPAA compliant virtual ecosystem: ~4,700 active monthly sites across 26 countries with ~300,000 patients per month. Glooko transforms digital health by connecting people with diabetes and their health care professionals, enabling telehealth, clinical research, and improved collaboration. We collect and unlock the power of data from blood-glucose meters, CGMs, insulin pumps, pens, and activity trackers – bringing insights together in one place. • World leaders trust Glooko solutions in diabetes care • 2.8 million users have benefited from diabetes data insights • People with diabetes and their health teams are benefiting from Glooko solutions in 26 countries across 15 languages FEATURES Real-World Data sources: BGMs/CGMs, pumps, smart pens, health apps, EHR*, EDC integration API*, and lifestyle devices. Secure Data Collection and Analytics: • Ability to sync blood glucose, medication, and fitness data via bluetooth and Apple Health. • Secure remote participate data upload and monitoring • Data analytics-aggregation of connected device data for direct export to EDC. • HIPAA compliant secure data transmission via API or FTP Digital Remote Solutions (Participant): • Glooko(R) Mobile App • Glooko Mobile Insulin Dosing System (MIDS) - FDA cleared • Glooko Remote Patient Monitoring Digital Remote Solutions (Investigator): • Glooko(R) Population Tracker • Scheduled clinic population health reporting Trial Management Tools and Support: • Participant monitoring platform (before/during/after intervention) • Study project management • Trial clinical support *Future development
VX
Read full descriptionHide full description
The purpose of this study is to learn more about the safety, tolerability, and efficacy of an investigational product in people with Type 1 Diabetes. The goal is to try to provide replacement islet cells for the ones that are lost or don’t work properly in people with diabetes.
Screenshots
Verdict
The clearest difference is update cadence: Glooko Research at every 3 months against VX's every 15 months. VX's advantage is iOS requirement (12.0 vs 14.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Glooko Research ships an update every 3 months, VX every 15 months. The most recent releases landed on October 4, 2026 and October 7, 2026 respectively.
| Parameter | Glooko Research | VX |
|---|---|---|
| Price | Free | Free |
| Rating | 3.0 (4 ratings) — better | — |
| Positive reviews | 0.0% of reviews | — |
| Number of ratings | 4 — better | — |
| Update frequency | Every 3 months — better | Every 15 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPod | iPhone, iPad, iPod — better |
| Requires iOS | 14.0 | 12.0 — better |
| Further details — not scored | ||
| Size | 127 MB | 148 MB |
| Age rating | 4+ | 17+ |
| Developer | Glooko, Inc. | Hello Thread |
In-app purchases
Glooko Research
No in-app purchases
VX
No in-app purchases
